About CTI Life Sciences

Based in Montreal, CTI Life Sciences Fund, a Canadian venture firm, makes venture capital investments in high quality emerging life sciences companies at the preclinical and clinical development stage in Canada and in the U.S.A. CTI Life Sciences Fund currently manages $245 million of assets.

For more information, visit

About Servier

Servier is an international pharmaceutical company governed by a non-profit foundation, with its headquarters in France (Suresnes). With a strong international presence in 149 countries and a turnover of 4.152 billion € in 2017, Servier employs 21,700 people worldwide. Entirely independent, the company reinvests 25% of its turnover (princeps drugs) in research and development and uses all its profits for development. Corporate growth is driven by Servier’s constant search for innovation in five areas of excellence: cardiovascular, immune-inflammatory and neuropsychiatric diseases, cancer and diabetes, as well as by its activities in high-quality generic drugs. Servier also offers eHealth solutions beyond drug development.

Servier Canada Inc., the Canadian affiliate of Servier, was established in 1978 and is investing in clinical research for the last twenty years in Canada. It is currently marketing innovative medicines in cardiology, oncology, diabetes as well as operating on the consumer health market.

For more information, visit

About Fonds de solidarité FTQ

Fonds de solidarité FTQ is an investment fund that makes use of Quebecers’ savings. With net assets of $14.8 billion, the Fonds has been investing in the development of thousands of businesses impacting Quebec’s economy for more than 35 years. It offers customized financing and works alongside companies with a long-term growth perspective. The Fonds is partnering with 2,839 businesses and is backed by 667,000 individual investors.

To find out more, please visit